Target intelligence / Profile preview

Ocular surface tear film and mucous layer (PTF)

Target
PTF
Molecular classification
Other
01

Overview

The ocular surface tear film and mucous layer is a complex, dynamic fluid system that covers the cornea and conjunctiva, serving as the primary interface between the eye and the environment. It is traditionally described as a tri-layered structure consisting of an outer lipid layer (produced by meibomian glands), a middle aqueous layer (produced by lacrimal glands), and an inner mucin layer (secreted by goblet cells), though modern models describe it as a unified mucoaqueous gel (TFOS DEWS II, 2017). This system is vital for maintaining a smooth refractive surface for clear vision, providing lubrication to minimize friction during blinking, and delivering oxygen and nutrients to the avascular corneal epithelium (StatPearls, 2023). In pathological states such as Dry Eye Disease (DED), the tear film loses homeostasis, leading to hyperosmolarity and inflammation that can damage the ocular surface (NIH, 2022). Therapeutic strategies targeting this system include the use of lubricants to replenish volume, lipid-based emulsions to reduce evaporation, and anti-inflammatory agents like cyclosporine to improve the quality and quantity of natural tear production (PubMed, 2021). Effective management of the tear film is essential for preventing corneal scarring and maintaining long-term visual acuity.

Other names
Precorneal tear filmTear filmLacrimal filmOcular surface fluid
02

Mechanism of action

The mechanism of action involves the supplementation of tear volume, stabilization of the lipid layer to prevent evaporation, and the reduction of ocular surface inflammation to restore the homeostatic environment of the tear film (StatPearls, 2023; TFOS DEWS II, 2017).

03

Biological functions

LubricationRefractionImmune responseOther
04

Disease associations

InflammationOther
05

Safety considerations

Ocular stinging or burningTransient blurred visionPreservative-induced ocular surface toxicityRisk of secondary ocular infection
06

Interacting drugs

Cyclosporine

6 more in the full profile.

07

Biomarkers

Tear Break-Up Time (TBUT)Tear osmolaritySchirmer test scoreMatrix metalloproteinase-9 (MMP-9)

Beyond the preview

Go deeper on Ocular surface tear film and mucous layer (PTF).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ocular surface tear film and mucous layer (PTF).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call